Etiqueta: Finlay Vaccine Institute
Cuba has the highest rate of recovered COVID-19 patients in the Americas
With the highest rate of patients recovered from COVID-19 in the Americas -94.2% as of March 20 – and two candidate vaccines in the final stage of clinical trials, Cuba is consolidating its national strategy to confront the pandemic…
Soberana 02, the first Latin American vaccine in phase III trials
Soberana 02- As the COVID-19 battle continues, the Cuban candidate vaccine becomes the first of its kind in Latin America to reach this stage
Cuba scales up industrial production of candidate vaccines
Cuba- Industrial production has begun of Cuba’s candidate vaccines Soberana 02 and Abdala (CIGB-66), two of the four developed on the island to combat COVID-19, with progress advancing at BioCubaFarma facilities
Cuba readies 100 million doses of anti-COVID vaccine
Finlay Vaccine Institute director, Dr. Vicente Vérez Bencomo, reports that Cuba is creating capacity to produce 100 million doses of the Soberana 02 vaccine
Soberana 02 clinical trials expanded
Soberana 02 clinical trials expanded. First steps for participating volunteers include signing an informed consent document and evaluation by medical staff